Effects of yohimbine, an α2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension

Fundamental and Clinical Pharmacology

Volumn 11, Issue 6, 1997, Pages 567-575

  Verwaerde, P ^a   Tran, M A ^a   Montastruc, J L ^a   Senard, J M ^a   Portolan, G ^a  

^a INSERM   (France)

Author keywords

Catecholamines; Orthostatic hypotension; Sinoaortic denervation; Spectral analysis; Tilting; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DENERVATION; DIASTOLIC BLOOD PRESSURE; HEART RATE VARIABILITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TILTING;

EID: 0030665749     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00862.x     Document Type: Article

References (40)

1. Ahmad RAS, Watson RDS. Treatment of postural hypotension: a review. Drugs 1990;39:74-85
2. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-2
3. Berlan M, Galitzky J, Rivière D, Foureau M, Tran MA, Flores R et al. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women, Int J Obesity 1991;15:305-15
4. 2-adrenoceptor antagonist therapy. Trends Pharmacol Sci 1992;13:277-82
5. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 1994;34:418-23
6. Cerutti C, Gustin MP, Paultre CZ, Lo M, Julien C, Vincent M, Sassard J. Role of the autonomic nervous system in blood pressure and heart rate variability in rats: a spectral analysis approach. In: Di Rienzo M et al. Blood Pressure and Heart Rate Variability. Amsterdam: IOS Press, 1992;180-91
7. Consensus Committee of the American Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomie failure and multiple system atrophy. Neurology 1996;46:1470
8. Elghozi JL, Laude D, Janvier F. Clonidine reduces blood pressure and heart rate oscillations in hypertensive patients. J Cardiovasc Pharmacol 1991;17:935-40
9. 2-adrenergic antagonist yohimbine on orthostatic tolerance. Hypertension 1990;15:877-80
10. Galitzky J, Rivière D, Tran MA, Montastruc JL, Berlan M. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers. Eur J Pharmacol 1990;39:447-51
11. 2-adrenoceptor. Pharmacol Rev 1983;35:143-80
12. Grichois ML, Japundzic N, Head G, Elghozi JL. Clonidine reduces blood pressure and heart rate oscillations in the conscious rat. J Cardiovasc Pharmacol 1990;16:449-54
13. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 1991;260: R142-7
14. Grunhaus SK, Tiongco D, Zelnik T, Flegel P, Hollingsworth PM, Smith CB. Intravenous yohimbine: selective enhancer of norepinephrine and cortisol secretion and systolic blood pressure in humans. Clin Neuropharmacol 1989;12:106-14
15. Hedman AE, Hartikaienen JEK, Tahvanainen KUO, Hakumäki MOK. Power spectral analysis of heart rate and blood pressure variability in anaesthetized dogs. Acta Physiol Scand 1992;146:155-64
16. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ et al. International union of pharmacology classification of receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol Rev 1994;46:157-203
17. Janssen BJA, Tyssen CM, Struyker-Boudier HAJ. Modification of circadian blood pressure and heart rate variability by five different antihypertensive agents in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991;17:494-503
18. Lacomblez L, Bensimon G, Isnard F, Diquet B, Lecubrier Y, Puech A. Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. Clin Pharmacol Ther 1989;45:241-51
19. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;82:482-92
20. Murphy CA, Sloan RP, Myers MM. Pharmacological responses and spectral analysis of spontaneous fluctuations in heart rate and blood pressure in SHR rats. J Auton Nerv Syst 1991;36:237-50
21. Onrot J, Goldberg MR, Hollister AS, Baggioni I, Robertson RM, Robertson D. Management of chronic orthostatic hypotension. Am J Med 1986;80:454-64
22. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-93
23. Pagani M, Rimoldi O, Malliani A. Low-frequency components of cardiovascular variabilities as markers of sympathetic modulation. Trends Pharmacol Sci 1992;13:50-4
24. Poncet MF, Damase-Michel C, Tavernier G, Tran MA, Berlan M, Montastruc JL, Montastruc P. Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs. Br J Pharmacol 1992;105:181-3
25. 2-adrenoceptor agonists and antagonists in the functional assessment of the sympathetic nervous system. J Clin Invest 1986;78:576-81
26. Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R, Robertson RM. The diagnosis and treatment of baroreflex failure. N Engl J Med 1993;329: 1449-55
27. Senard JM, Valet P, Durrieu G, Berlan M, Tran MA, Montastruc JL et al. Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension. Eur J Clin Invest 1990;20: 613-9
28. Senard JM, Chamontin B, Rascol A, Montastruc JL. Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res 1992;2:99-104
29. Senard JM, Rascol O, Durrieu G, Tran MA, Berlan M, Rascol A, Montastruc JL. Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson's disease or multiple system atrophy. Clin Neuropharmacol 1993a;16:70-6
30. Senard JM, Rascol O, Rascol A, Montastruc JL. Lack of yohimbine effect on ambulatory blood pressure recording: a double blind cross-over trial in Parkinsonians with orthostatic hypotension. Fundam Clin Pharmacol 1993b;7:465-70
31. Senard JM, Montastruc JL. Which drug for which orthostatic hypotension? Fundam Clin Pharmacol 1996;10:225-33
32. Sleight P, La Rovene MT, Montana A, Pinna G, Maestri R, Leuzzi S et al. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci 1995;88:103-9
33. Stauss HM, Persson PB. Power spectral analysis of heart rate and blood pressure markers for autonomic balance or indicators of baroreflex control? Clin Sci 1995;88:1-2
34. Szabo B, Hedler L, Starke K. Peripheral presynaptic and central effects of clonidine, yohimbine and rawolscine on the sympathetic nervous system in rabbits. Naunyn Schmiedebergs Arch Pharmacol 1989;340:648-57
35. Szabo B, Schramm A, Starke K. Effect of yohimbine on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits. J Pharmacol Exp Ther 1992; 260:780-8
36. Tavernier G, Damase-Michel C, Portolan G, Tran MA, Montastruc JL. Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation? Naunyn Schmiedebergs Arch Pharmacol 1992;345:431-6
37. Valet P, Damase-Michel C, Montastruc JL, Montastruc P. Plasma catecholamines and adrenoceptors after chronic sinoaortic denervation in dogs. Fundam Clin Pharmacol 1989;3:307-20
38. Verwaerde P, Senard JM, Mazerolles M, Tran MA, Damase-Michel C, Montastruc JL, Montastruc P. Spectral analysis of blood pressure and heart rate, catecholamine and neuropeptide Y plasma levels in a new model of neurogenic orthostatic hypotension in dog. Clin Auton Res 1996; 6:1-8
39. Winter JC, Rabin RA. Yohimbine as a serotoninergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 1992;263:682-9
40. Yeragani VK, Berger R, Polh R, Srinivasan K, Balon R, Ramesh C et al. Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate. J Cardiovasc Pharmacol 1992;20:609-18